BioCentury
ARTICLE | Financial News

Revance amends IPO

February 3, 2014 8:00 AM UTC

Revance Therapeutics Inc., Newark, Calif. Business: Dermatology Date announced: 1/27/14 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: Cowen; Piper Jaffray; B...